http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0081896-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
filingDate 1982-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e1003f0641273d54e5dec51d6c43c9e
publicationDate 1983-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0081896-A2
titleOfInvention Waterless thixotropic composition
abstract A waterless thixotropic composition of a medicament, particularly for oral administration, comprises from 0.5 to 10% by weight of a drug having a therapeutic or prophylactic effect on a condition affecting an animal, from 2 to 25% by weight of a hydroxylated fatty acid ester of glycerin, from 55 to 97.2% by weight of a glycol or glycerin; and from 0.3 to 15% by weight of a water-soluble polymer. Waterless compositions are particularly necessary where water content would result in decomposition of the medicament formulation.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7854943-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0177893-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0177893-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7622138-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8353877-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9602228-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7858115-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8758831-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-592065-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9180249-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7618651-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7828765-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8361496-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7846472-B2
priorityDate 1981-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410119169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226568723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453111986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425730994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69417

Total number of triples: 48.